These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8206192)

  • 21. When to treat the hypertensive diabetic patient.
    Fuller JH
    J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin sensitivity and the effects of antihypertensive agents: implications for the treatment of hypertension in the patient with diabetes mellitus.
    Simonson DC
    Postgrad Med J; 1988; 64 Suppl 3():39-47; discussion 48-9. PubMed ID: 3074296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
    CDC Diabetes Cost-effectiveness Group
    JAMA; 2002 May; 287(19):2542-51. PubMed ID: 12020335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current cost analysis in the management of diabetes mellitus].
    Oberender P
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S110-4; discussion S124-6. PubMed ID: 18686219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of non-insulin dependent diabetes (type 2 diabetes mellitus)].
    Hanssen KF; Jenssen T
    Tidsskr Nor Laegeforen; 1992 Mar; 112(7):912-4. PubMed ID: 1557762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Costs of antihyperglycemic treatment and consumables and treatment satisfaction in patients with type 2 diabetes].
    Schröder J; Kerner W
    Dtsch Med Wochenschr; 2009 Nov; 134(46):2355; author reply 2355-6. PubMed ID: 19894207
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertension in patients with diabetes: questions.
    Bloomgarden Z; Guang N
    J Diabetes; 2010 Sep; 2(3):128-9. PubMed ID: 20923477
    [No Abstract]   [Full Text] [Related]  

  • 32. Diuretics accelerate diabetic nephropathy in hypertensive insulin-dependent and non-insulin-dependent subjects.
    Walker WG; Hermann J; Yin DP; Murphy RP; Patz A
    Trans Assoc Am Physicians; 1987; 100():305-15. PubMed ID: 3455072
    [No Abstract]   [Full Text] [Related]  

  • 33. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Economics under scrutiny - experts discuss long acting insulin analogs].
    Pflege Z; 2011 Jan; 64(1):58. PubMed ID: 21305792
    [No Abstract]   [Full Text] [Related]  

  • 35. [New targets for blood pressure lowering in diabetic patients?].
    Kintscher U
    Dtsch Med Wochenschr; 2010 Dec; 135(48):2417-9. PubMed ID: 21082543
    [No Abstract]   [Full Text] [Related]  

  • 36. [Incidence of coronary cardiopathy in 416 diabetic patients treated with insulin or oral hypoglycemic agents].
    Comi D; Santagostino A; Ragaini S; Baroni GC; Porro T; Pagani G
    Boll Soc Ital Cardiol; 1975; 20(1):73-80. PubMed ID: 1231897
    [No Abstract]   [Full Text] [Related]  

  • 37. The cost-effectiveness of doxazosin for the treatment of hypertension in type II diabetic patients in the UK and Italy.
    Casciano J; Doyle J; Casciano R; Kopp Z; Marchant N; Bustacchini S; Arikian S; Kim R
    Int J Clin Pract; 2001 Mar; 55(2):84-92. PubMed ID: 11321866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.
    Brown JB; Nichols GA; Glauber HS; Bakst AW
    Diabetes Care; 1999 Jul; 22(7):1116-24. PubMed ID: 10388977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization].
    Hanaire H; Attali C; Lecointre B; Fraysse M; Gouet D; Babel MR; Charbonnel B; Sarkozy F; Gourmelen J; Detournay B
    Sante Publique; 2016 Dec; 28(6):781-789. PubMed ID: 28155773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data.
    Sancho-Mestre C; Vivas-Consuelo D; Alvis-Estrada L; Romero M; Usó-Talamantes R; Caballer-Tarazona V
    BMC Health Serv Res; 2016 Aug; 16(1):394. PubMed ID: 27534391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.